NO20010021L - Trifunksjonelt reagens for konjugering til et biomolekyl - Google Patents
Trifunksjonelt reagens for konjugering til et biomolekylInfo
- Publication number
- NO20010021L NO20010021L NO20010021A NO20010021A NO20010021L NO 20010021 L NO20010021 L NO 20010021L NO 20010021 A NO20010021 A NO 20010021A NO 20010021 A NO20010021 A NO 20010021A NO 20010021 L NO20010021 L NO 20010021L
- Authority
- NO
- Norway
- Prior art keywords
- biomolecule
- reagent
- conjugation
- linker
- moiety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SE1998/001345 WO2000002050A1 (en) | 1998-07-07 | 1998-07-07 | Trifunctional reagent for conjugation to a biomolecule |
| PCT/SE1999/001241 WO2000002051A1 (en) | 1998-07-07 | 1999-07-07 | Trifunctional reagent for conjugation to a biomolecule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010021D0 NO20010021D0 (no) | 2001-01-03 |
| NO20010021L true NO20010021L (no) | 2001-03-07 |
Family
ID=20410995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010021A NO20010021L (no) | 1998-07-07 | 2001-01-03 | Trifunksjonelt reagens for konjugering til et biomolekyl |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1095274B1 (de) |
| JP (1) | JP2002519440A (de) |
| AT (1) | ATE483162T1 (de) |
| AU (2) | AU8366398A (de) |
| CA (1) | CA2336739A1 (de) |
| DE (1) | DE69942802D1 (de) |
| NO (1) | NO20010021L (de) |
| WO (2) | WO2000002050A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9100142L (sv) | 1991-01-17 | 1992-07-18 | Bengt Sandberg | En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal |
| US8951499B2 (en) | 1996-02-08 | 2015-02-10 | University Of Washington | Trifunctional reagent for conjugation to a biomolecule |
| DE10012120A1 (de) * | 2000-03-13 | 2001-09-27 | Ktb Tumorforschungs Gmbh | Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel |
| US7183392B2 (en) | 2000-03-27 | 2007-02-27 | Zyomyx, Inc. | Site-specific, covalent bioconjugation of proteins |
| SE0002287D0 (sv) | 2000-06-16 | 2000-06-16 | Department Of Radiation Oncolo | Biotinderivat |
| FR2814463B1 (fr) | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| AU2001296124A1 (en) * | 2000-10-12 | 2002-04-22 | Mitra Medical Technology Ab | Kit for intraperitoneal administration and extracorpeal removal of a drug |
| US20030031677A1 (en) * | 2001-06-25 | 2003-02-13 | Drug Innovation & Design, Incorporated | Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| DE10227599B4 (de) * | 2002-06-20 | 2005-04-28 | Proteome Factory Ag | Verfahren und Reagenz zur spezifischen Identifizierung und Quantifizierung von einem oder mehreren Proteinen in einer Probe |
| CA2509103A1 (en) * | 2002-12-13 | 2004-07-01 | Mitra Medical Technology Ab | Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| US7438893B2 (en) * | 2003-10-02 | 2008-10-21 | Massachusetts General Hospital | Polybiotin compounds for magnetic resonance imaging and drug delivery |
| JP2007512324A (ja) * | 2003-11-28 | 2007-05-17 | ミトラ、メディカル、アクチボラグ | Erb抗原のターゲッティング |
| US20110014151A1 (en) * | 2006-01-11 | 2011-01-20 | Biotech Igg Ab | Macromolecule conjugate |
| US8106154B2 (en) | 2007-01-31 | 2012-01-31 | Affymax, Inc. | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
| EP2152312B1 (de) | 2007-05-16 | 2014-12-31 | KTB Tumorforschungsgesellschaft mbH | Niedrigviskose anthracyclinformulierung |
| WO2008145609A1 (en) * | 2007-05-25 | 2008-12-04 | Novartis Ag | Method of making covalent conjugates with his-tagged proteins |
| FR2918664B1 (fr) * | 2007-07-11 | 2009-10-02 | Commissariat Energie Atomique | Reactif pseudo peptidique trifonctionnel, ses utilisations et applications. |
| FI20090100A0 (fi) | 2009-03-16 | 2009-03-16 | Wallac Oy | Biotinidaasimääritys |
| CA2825066C (en) | 2011-01-31 | 2019-09-03 | Eth Zurich | Trifunctional crosslinking reagents comprising a succinimide, a hydrazone and an affinity group |
| GB201205360D0 (en) * | 2012-03-27 | 2012-05-09 | Univ Edinburgh | Biotinidase resistant biotinyl compounds |
| EP3929587A1 (de) * | 2020-06-25 | 2021-12-29 | Technische Universität Berlin | Vernetzungsreagenz für die biokonjugation zur verwendung bei der proteomik-vernetzung, insbesondere der vernetzungsmassenspektrometrieanalyse |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0310361A3 (de) * | 1987-09-30 | 1989-05-24 | Beckman Instruments, Inc. | Aus drei Verzahnungen bestehendes Konjugat und Verfahren zu seiner Verwendung |
| GB8809616D0 (en) * | 1988-04-22 | 1988-05-25 | Cancer Res Campaign Tech | Further improvements relating to drug delivery systems |
| US5310916A (en) * | 1988-07-19 | 1994-05-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors |
| US5134071A (en) * | 1989-02-06 | 1992-07-28 | State University Of New York | Polymerization and copolymerization of proteins |
| EP0596011A1 (de) * | 1991-07-19 | 1994-05-11 | Hybritech Incorporated | Trifunktionelle verbindungen mit spezifizitaet fuer multi-drug resistente zellen |
| DE4310141A1 (de) * | 1993-03-29 | 1994-10-06 | Boehringer Mannheim Gmbh | Homobidentale trifunktionelle Linker |
| US5686578A (en) * | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| WO1997029114A1 (en) * | 1996-02-08 | 1997-08-14 | Board Of Regents Of The University Of Washington | Biotin-containing compounds, biotinylation reagents and methods |
| DE69837706T2 (de) * | 1997-07-21 | 2008-01-10 | Active Biotech Ab | Zytolyse der geeigneten zielzellen mit superantigen konjugate mittels der induktion von t-zell aktivierung |
-
1998
- 1998-07-07 WO PCT/SE1998/001345 patent/WO2000002050A1/en not_active Ceased
- 1998-07-07 AU AU83663/98A patent/AU8366398A/en not_active Abandoned
-
1999
- 1999-07-07 AT AT99935251T patent/ATE483162T1/de not_active IP Right Cessation
- 1999-07-07 JP JP2000558395A patent/JP2002519440A/ja active Pending
- 1999-07-07 CA CA002336739A patent/CA2336739A1/en not_active Abandoned
- 1999-07-07 AU AU50767/99A patent/AU5076799A/en not_active Abandoned
- 1999-07-07 WO PCT/SE1999/001241 patent/WO2000002051A1/en not_active Ceased
- 1999-07-07 EP EP99935251A patent/EP1095274B1/de not_active Expired - Lifetime
- 1999-07-07 DE DE69942802T patent/DE69942802D1/de not_active Expired - Lifetime
-
2001
- 2001-01-03 NO NO20010021A patent/NO20010021L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000002050A1 (en) | 2000-01-13 |
| JP2002519440A (ja) | 2002-07-02 |
| AU5076799A (en) | 2000-01-24 |
| DE69942802D1 (de) | 2010-11-11 |
| ATE483162T1 (de) | 2010-10-15 |
| AU8366398A (en) | 2000-01-24 |
| EP1095274A1 (de) | 2001-05-02 |
| WO2000002051A1 (en) | 2000-01-13 |
| CA2336739A1 (en) | 2000-01-13 |
| NO20010021D0 (no) | 2001-01-03 |
| EP1095274B1 (de) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20010021D0 (no) | Trifunksjonelt reagens for konjugering til et biomolekyl | |
| ATE407943T1 (de) | Zielsuchende verbindungen für verschiedene organe und gewebe | |
| DE50014571D1 (de) | Träger-pharmaka-konjugate | |
| NO20005694L (no) | Spesifikke bindingsmolekyler for scintigrafi, konjugater som inneholder disse og terapeutiske fremgangsmåter for behandling av angiogenese | |
| CY1110579T1 (el) | Η λειτουργια ενος υποδοχεα απτοσφαιρινης-αιμοσφαιρινης και οι χρησεις αυτου | |
| PL374875A1 (en) | Detecting receptor oligomerization | |
| CA2336564A1 (en) | Method for preparing water-soluble cross-linked conjugates | |
| DE69533725D1 (de) | Multifunktionelle molekuläre komplexe für den gen-transfer in zellen | |
| WO2003049684A3 (en) | Pseudo-antibody constructs | |
| ATE341344T1 (de) | Polypeptide mit einzelnem kovalent gebundenen n- terminalen wasserlöslichen polymer | |
| MY112488A (en) | Process for preparing 1-(2''-deoxy-2'',2''-difluoro-d- ribofuranosyl)-4-aminopyrimidin-one) hydrochloride | |
| WO2008027944A3 (en) | Antigenic protein conjugates and process for preparing same | |
| DK1053355T3 (da) | PNA- og DNA-konjugater og metoder til fremstilling heraf | |
| KR910005862A (ko) | 신규 친수성 유도체, 진단 또는 치료시 그의 응용 그를 함유하는 진단 또는 치료용 키트 및 면역 시약 | |
| NO971228D0 (no) | Vater | |
| ES2077098T3 (es) | Proteinas modificadas con sacaridos, solubles en agua. | |
| WO1998009647A3 (en) | Cyanidin compositions and therapeutic and diagnostic uses therefor | |
| FR2735238B1 (fr) | Utilisation d'un complexe phycobiliproteine-peptide de liaison en tant que traceur fluorescent | |
| JP2002542820A5 (de) | ||
| McIlhinney et al. | A simple and rapid method for the production of cholera B-chain coupled to horseradish peroxidase for neuronal tracing | |
| CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
| DE60031990D1 (de) | Synthetische verbindungen mit zwei epitopen für immunoassays | |
| ATE141926T1 (de) | Neue cobalamin-säurehydrazide und davon abgeleitete cobalamin-konjugate | |
| AU2001292118A1 (en) | Dye-labelled peptide and its diagnostic use | |
| Habuchi et al. | Sea urchin egg receptor for sperm: the oligosaccharide chains stabilize sperm binding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |